high dropout for vomiting [Study As­sess­ment]

posted by zheng791 – US, 2013-09-26 18:13 (4652 d 01:32 ago) – Posting: # 11566
Views: 5,192

Hi All,
Our CRO just dosed the drug for fed and fasting BE study. This drug is for rare disease, causing 1/3 of patients vomit in literature. The calculated sample size is 35 sub for each condition, and we added up to 51 for 3 way. Now for the Period I, 19 and 31 subjects could not continue because of vomiting.

I back to check the literature, one research BE paper in fed condition, 24 sub enrolled, and 17 completed for 2 way and the drug still passed (intra CV is ~20%).

This the first time I have such tough drug. CRO gave several choices:
1。The CRO suggests Ondacetron could be used anti-vomiting.
2. Start over with more subjects
3. continue the current trials

Any suggestion for the tough one?

Thank you very much


Edit: Category changed. [Helmut]

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
136 visitors (0 registered, 136 guests [including 30 identified bots]).
Forum time: 19:45 CEST (Europe/Vienna)

Scientists cannot simply hang their subjectivities
up on a hook outside the laboratory door.    Ruth Bleier

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5